Seven Years After Prostatectomy, His PSA Was 0.03

The result arrived in his patient portal before a long holiday weekend. He was 64, still working as an accountant, and sitting at the kitchen table with a folder of retirement estimates beside him when he opened the lab report.

The line read: PSA 0.03 ng/mL.

For seven years, that same line had shown less than 0.01. He understood those earlier results as undetectable, which was the word his specialist had used and the word he repeated to his wife after every blood draw. This one was small.

It was also there.

He refreshed the page. The line remained.

His prostate had been removed after a prostate cancer diagnosis in his 50s. Surgery was followed by appointments that became less frequent as the years passed, and the blood tests gradually lost some of their power over the days around them. He still noticed the week before each result. He did not call it anxiety.

He checked the portal more often and slept less. Then another undetectable result would appear, and ordinary life would resume.

Seven years had begun to feel like distance.

The 0.03 result changed that feeling before anyone from his doctor’s office had interpreted it. The portal showed the reference information and the laboratory’s notation, but it could not tell him whether the number reflected a meaningful rise, a difference in testing sensitivity, or the beginning of a recurrence. It gave him data without context, then left him with several days in which the office was closed.

The holiday weekend

He printed the result because paper felt easier to examine than a screen. The page sat beside the retirement folder, and the line PSA 0.03 ng/mL appeared each time he looked down, unchanged by how many explanations he considered.

His first feeling was fear. The second was anger that the result had been released when he could not reach the specialist who had followed him since surgery. He knew the portal was automated, and that knowledge did not make the timing easier.

His wife read the page once. She said they did not know what it meant yet. He agreed, then searched for the meaning anyway, moving through patient forums and medical pages until he found thresholds that seemed reassuring beside accounts from men whose recurrences had first appeared as numbers even lower than his.

The search did not resolve the contradiction. A PSA can be detectable without establishing recurrence, while a low result can still matter when it follows years of undetectable tests. Both statements were true. Neither told him what would happen to him.

They had planned to spend the weekend finalizing a six-week retirement trip through the Southwest. A paper map was open on the other end of the table, with a route penciled between national parks and the town where his wife’s sister lived. He had intended to retire in 19 months, after one more busy tax season and enough time to train the person expected to take over his larger accounts.

Now he stopped talking about reservations.

Nothing had happened to prevent the trip. No clinician had told him he needed treatment, and no appointment had been scheduled. Still, the possibility of more care entered every calculation: insurance after leaving work, time away for appointments, the savings they had expected to use during their first years of retirement.

As an accountant, he was accustomed to figures that reconciled. The line in the portal did not.

He felt embarrassed by how quickly he had revised a future that had not yet changed. That embarrassment eased when he told another prostate cancer survivor, who understood why a number far below one could feel large after years of seeing less than 0.01. Fear in that setting was not an overreaction.

It was a response to having once been ill and knowing that follow-up tests existed for a reason.

A result, then a trend

After the holiday, the specialist’s office reviewed the lab report. The explanation was cautious. After prostatectomy, PSA is generally expected to remain undetectable, but laboratories can detect very small amounts, and one ultrasensitive result does not by itself show whether the value is rising in a consistent way.

A commonly used definition of biochemical recurrence after surgery involves a PSA of at least 0.2 ng/mL confirmed by another test. His specialist also explained that care teams may pay attention to lower values and how they change over time, particularly when considering whether further evaluation could become relevant. The definition did not make 0.

03 meaningless. It kept the result from becoming an immediate answer.

The office arranged another blood test for eight weeks later.

Waiting for that test was harder than he expected because there was no task that could settle the matter sooner. He went to work. He reviewed returns and answered clients whose questions had clear responses, while his own result stayed open in a portal tab he had promised himself not to check during the day.

At home, the printed page remained in the retirement folder. He could have thrown it away; the result was stored online. Instead, he kept it near the estimates for health insurance and monthly income, documents that had once seemed to cover the uncertainties ahead.

The repeat PSA was 0.03.

He felt relief, then distrusted it. The number had not risen, but it had not returned to less than 0.01. His specialist described the stable result as useful information and arranged another test four months later, allowing more time to see whether a pattern emerged.

During those months, he began noticing the unfinished parts of retirement planning. He and his wife had not decided whether to keep the house. He had not told his business partner the month he intended to leave. The trip remained a route on paper rather than a reservation they could change or cancel.

He had once assumed that remission meant reaching a point where cancer belonged to the past. Survivorship had been quieter and less final than that, though most days he had not needed to think about it. The blood tests continued because certainty did not.

The next decimal

The third result was 0.04 ng/mL.

The change was one hundredth of a nanogram per milliliter. His care team did not treat it as proof of what would happen next, but the movement made the earlier result harder to dismiss as an isolated reading. The specialist discussed continued monitoring and the possibility of consultation with another cancer specialist if the upward pattern persisted. There was still no immediate treatment decision.

He wanted a firm category: recurrence or no recurrence. What he received was a concerning trend that needed more time.

This was different from being told nothing. The repeated tests had established that the first detectable result was not followed by a return to his earlier range, and the small rise mattered to the people caring for him. Yet the information remained incomplete, which meant his fear could not attach itself to a plan with a beginning and an end.

He and his wife booked the first part of the retirement trip with cancellation options. He also told his business partner that he still intended to leave in 19 months, though he might need flexibility for medical appointments. Speaking the plan aloud did not restore the certainty he had before the portal result. It let the plan exist beside the uncertainty.

The printed 0.03 result stayed in the folder. Over time, it became less a document he studied and more a record of the weekend when he had believed one line could tell him everything. It had told him something.

More than he wanted, and less than he needed.

Questions people ask

Does a detectable

PSA after prostatectomy mean the cancer has returned?

A detectable result can be concerning after prostatectomy, but one low value may not establish recurrence. In this story, the specialist considered the assay’s sensitivity, prior undetectable results, and later measurements. The first 0.03 result prompted repeat testing rather than an immediate conclusion.

Why are repeat

PSA tests used after a low detectable result?

Repeat tests show whether a value returns to the earlier range, remains stable, or rises over time. His second result stayed at 0.03, while a later test reached 0.04.

That sequence gave his care team more information than the first portal line could provide alone.

Why did the result appear before his doctor explained it?

Patient portals often release laboratory results automatically, sometimes before a clinician has reviewed them. For him, that meant seeing 0.03 before a holiday weekend and waiting several days for context. The delay did not change the result, but it shaped how alone he felt with it.

Can retirement plans continue while PSA is being monitored?

His plans became less certain, especially around insurance and time for possible appointments, but they did not disappear. He kept his intended retirement date, booked part of the trip with room to change it, and left the six-week route penciled on the paper map.